Works by Larocca, Alessandra

Results: 54
    1

    Correction: Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma.

    Published in:
    2025
    By:
    • Bandini, Cecilia;
    • Mereu, Elisabetta;
    • Paradzik, Tina;
    • Labrador, Maria;
    • Maccagno, Monica;
    • Cumerlato, Michela;
    • Oreglia, Federico;
    • Prever, Lorenzo;
    • Manicardi, Veronica;
    • Taiana, Elisa;
    • Ronchetti, Domenica;
    • D'Agostino, Mattia;
    • Gay, Francesca;
    • Larocca, Alessandra;
    • Besse, Lenka;
    • Merlo, Giorgio Roberto;
    • Hirsch, Emilio;
    • Ciarrocchi, Alessia;
    • Inghirami, Giorgio;
    • Neri, Antonino
    Publication type:
    Correction Notice
    2

    High rate of profound clonal and renal responses with daratumumab treatment in heavily pre‐treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 8, p. 900, doi. 10.1002/ajh.25828
    By:
    • Milani, Paolo;
    • Fazio, Francesca;
    • Basset, Marco;
    • Berno, Tamara;
    • Larocca, Alessandra;
    • Foli, Andrea;
    • Riva, Marcello;
    • Benigna, Francesca;
    • Oliva, Stefania;
    • Nuvolone, Mario;
    • Rodigari, Lara;
    • Petrucci, Maria Teresa;
    • Merlini, Giampaolo;
    • Palladini, Giovanni
    Publication type:
    Article
    3

    Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 3, p. 244, doi. 10.1002/ajh.24621
    By:
    • Gentile, Massimo;
    • Magarotto, Valeria;
    • Offidani, Massimo;
    • Musto, Pellegrino;
    • Bringhen, Sara;
    • Teresa Petrucci, Maria;
    • Gay, Francesca;
    • Larocca, Alessandra;
    • Uccello, Giuseppina;
    • Petrungaro, Annamaria;
    • Vigna, Ernesto;
    • Greco, Rosa;
    • Grazia Recchia, Anna;
    • Tripepi, Giovanni;
    • Ria, Roberto;
    • Di Raimondo, Francesco;
    • Palumbo, Antonio;
    • Morabito, Fortunato
    Publication type:
    Article
    4

    Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 4, p. 355, doi. 10.1002/ajh.23641
    By:
    • Morabito, Fortunato;
    • Bringhen, Sara;
    • Larocca, Alessandra;
    • Wijermans, Pierre;
    • Victoria Mateos, Maria;
    • Gimsing, Peter;
    • Mazzone, Carla;
    • Gottardi, Daniela;
    • Omedè, Paola;
    • Zweegman, Sonja;
    • José Lahuerta, Juan;
    • Zambello, Renato;
    • Musto, Pellegrino;
    • Magarotto, Valeria;
    • Schaafsma, Martijn;
    • Oriol, Albert;
    • Juliusson, Gunnar;
    • Cerrato, Chiara;
    • Catalano, Lucio;
    • Gentile, Massimo
    Publication type:
    Article
    5

    Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01096-6
    By:
    • Ziccheddu, Bachisio;
    • Giannotta, Claudia;
    • D'Agostino, Mattia;
    • Bertuglia, Giuseppe;
    • Saraci, Elona;
    • Oliva, Stefania;
    • Genuardi, Elisa;
    • Papadimitriou, Marios;
    • Diamond, Benjamin;
    • Corradini, Paolo;
    • Coffey, David;
    • Landgren, Ola;
    • Bolli, Niccolò;
    • Bruno, Benedetto;
    • Boccadoro, Mario;
    • Massaia, Massimo;
    • Maura, Francesco;
    • Larocca, Alessandra
    Publication type:
    Article
    6
    7

    Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score.

    Published in:
    2021
    By:
    • D'Agostino, Mattia;
    • Larocca, Alessandra;
    • Offidani, Massimo;
    • Liberati, Anna Marina;
    • Gaidano, Gianluca;
    • Petrucci, Maria Teresa;
    • Derudas, Daniele;
    • Capra, Andrea;
    • Zambello, Renato;
    • Cascavilla, Nicola;
    • de Fabritiis, Paolo;
    • Innao, Vanessa;
    • Bonello, Francesca;
    • Patriarca, Francesca;
    • Benevolo, Giulia;
    • Giuliani, Nicola;
    • Aitoro, Gabriele;
    • Guglielmelli, Tommasina;
    • Di Raimondo, Francesco;
    • Corradini, Paolo
    Publication type:
    Letter
    8

    Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00432-4
    By:
    • Terpos, Evangelos;
    • Mikhael, Joseph;
    • Hajek, Roman;
    • Chari, Ajai;
    • Zweegman, Sonja;
    • Lee, Hans C.;
    • Mateos, María-Victoria;
    • Larocca, Alessandra;
    • Ramasamy, Karthik;
    • Kaiser, Martin;
    • Cook, Gordon;
    • Weisel, Katja C.;
    • Costello, Caitlin L.;
    • Elliott, Jennifer;
    • Palumbo, Antonio;
    • Usmani, Saad Z.
    Publication type:
    Article
    9

    Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study.

    Published in:
    Leukemia & Lymphoma, 2010, v. 51, n. 8, p. 1444, doi. 10.3109/10428194.2010.486878
    By:
    • Offidani, Massimo;
    • Leoni, Pietro;
    • Bringhen, Sara;
    • Corvatta, Laura;
    • Larocca, Alessandra;
    • Gentili, Silvia;
    • Oliva, Stefania;
    • Polloni, Claudia;
    • Galieni, Piero;
    • Catarini, Massimo;
    • Alesiani, Francesco;
    • Mele, Anna;
    • Brunori, Marino;
    • Blasi, Nicola;
    • Ferranti, Mario;
    • Visani, Giuseppe;
    • Boccadoro, Mario;
    • Palumbo, Antonio
    Publication type:
    Article
    10
    11

    Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 8, p. 1850, doi. 10.1080/10428194.2020.1747066
    By:
    • Weisel, Katja;
    • Dimopoulos, Meletios;
    • Moreau, Philippe;
    • Yagci, Munci;
    • Larocca, Alessandra;
    • Kanate, Abraham S.;
    • Vural, Filiz;
    • Cascavilla, Nicola;
    • Basu, Supratik;
    • Johnson, Peter;
    • Byeff, Peter;
    • Hus, Marek;
    • Rodríguez-Otero, Paula;
    • Muelduer, Ercan;
    • Anttila, Pekka;
    • Hayden, Patrick J.;
    • Krauth, Maria-Theresa;
    • Lucio, Paulo;
    • Ben-Yehuda, Dina;
    • Mendeleeva, Larisa
    Publication type:
    Article
    12

    Melflufen for relapsed and refractory multiple myeloma.

    Published in:
    Expert Opinion on Investigational Drugs, 2020, v. 29, n. 10, p. 1069, doi. 10.1080/13543784.2020.1808884
    By:
    • Oriol, Albert;
    • Larocca, Alessandra;
    • Leleu, Xavier;
    • Hajek, Roman;
    • Hassoun, Hani;
    • Rodríguez-Otero, Paula;
    • Paner, Agne;
    • Schjesvold, Fredrik H.;
    • Gullbo, Joachim;
    • Richardson, Paul G.
    Publication type:
    Article
    13
    14

    MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients.

    Published in:
    British Journal of Haematology, 2014, v. 164, n. 6, p. 841, doi. 10.1111/bjh.12719
    By:
    • Rocci, Alberto;
    • Gambella, Manuela;
    • Aschero, Simona;
    • Baldi, Ileana;
    • Trusolino, Livio;
    • Cavallo, Federica;
    • Gay, Francesca;
    • Larocca, Alessandra;
    • Magarotto, Valeria;
    • Omedè, Paola;
    • Isaia, Gianluca;
    • Bertotti, Andrea;
    • Liberati, Anna M.;
    • Catalano, Lucio;
    • De Rosa, Luca;
    • Musto, Pellegrino;
    • Vallone, Roberto;
    • Falcone, Antonietta;
    • Drandi, Daniela;
    • Ladetto, Marco
    Publication type:
    Article
    15
    16

    Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study

    Published in:
    Stem Cell Research & Therapy, 2015, v. 6, n. 1, p. 1, doi. 10.1186/s13287-015-0033-1
    By:
    • Musto, Pellegrino;
    • Simeon, Vittorio;
    • Grossi, Alberto;
    • Gay, Francesca;
    • Bringhen, Sara;
    • Larocca, Alessandra;
    • Guariglia, Roberto;
    • Pietrantuono, Giuseppe;
    • Villani, Oreste;
    • D'Arena, Giovanni;
    • Cuomo, Carmela;
    • Musto, Clelia;
    • Morabito, Fortunato;
    • Petrucci, Maria Teresa;
    • Offidani, Massimo;
    • Zamagni, Elena;
    • Tacchetti, Paola;
    • Conticello, Concetta;
    • Milone, Giuseppe;
    • Palumbo, Antonio
    Publication type:
    Article
    17

    Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study

    Published in:
    Stem Cell Research & Therapy, 2015, v. 6, n. 1, p. 64, doi. 10.1186/s13287-015-0033-1
    By:
    • Musto, Pellegrino;
    • Simeon, Vittorio;
    • Grossi, Alberto;
    • Gay, Francesca;
    • Bringhen, Sara;
    • Larocca, Alessandra;
    • Guariglia, Roberto;
    • Pietrantuono, Giuseppe;
    • Villani, Oreste;
    • D’Arena, Giovanni;
    • Cuomo, Carmela;
    • Musto, Clelia;
    • Morabito, Fortunato;
    • Petrucci, Maria Teresa;
    • Offidani, Massimo;
    • Zamagni, Elena;
    • Tacchetti, Paola;
    • Conticello, Concetta;
    • Milone, Giuseppe;
    • Palumbo, Antonio
    Publication type:
    Article
    18
    19
    20

    Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation.

    Published in:
    2020
    By:
    • Apolito, Vincenzo;
    • Giaccone, Luisa;
    • Ferrero, Simone;
    • Larocca, Alessandra;
    • Cavallo, Federica;
    • Coscia, Marta;
    • Beggiato, Eloise;
    • Butera, Sara;
    • Martella, Federica;
    • Dainese, Cristina;
    • Cetani, Giusy;
    • Scaldaferri, Matilde;
    • Cattel, Francesco;
    • Boccadoro, Mario;
    • Ferrero, Dario;
    • Bruno, Benedetto;
    • Cerrano, Marco
    Publication type:
    Letter
    21
    22

    Treatment of newly diagnosed multiple myeloma.

    Published in:
    Current Hematologic Malignancy Reports, 2008, v. 3, n. 2, p. 107, doi. 10.1007/s11899-008-0016-8
    By:
    • Palumbo, Antonio;
    • Magarotto, Valeria;
    • Larocca, Alessandra;
    • Bringhen, Sara;
    • Falco, Patrizia;
    • Raimondo, Francesco;
    • Baldini, Luca;
    • Boccadoro, Mario
    Publication type:
    Article
    23

    Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis.

    Published in:
    2019
    By:
    • Gambella, Manuela;
    • Omedé, Paola;
    • Spada, Stefano;
    • Muccio, Vittorio Emanuele;
    • Gilestro, Milena;
    • Saraci, Elona;
    • Grammatico, Sara;
    • Larocca, Alessandra;
    • Conticello, Concetta;
    • Bernardini, Annalisa;
    • Gamberi, Barbara;
    • Troia, Rossella;
    • Liberati, Anna Marina;
    • Offidani, Massimo;
    • Rocci, Alberto;
    • Palumbo, Antonio;
    • Cavo, Michele;
    • Sonneveld, Pieter;
    • Boccadoro, Mario;
    • Oliva, Stefania
    Publication type:
    journal article
    24
    25
    26

    The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens.

    Published in:
    Cancer (0008543X), 2011, v. 117, n. 9, p. 1884, doi. 10.1002/cncr.25743
    By:
    • Benevolo, Giulia;
    • Larocca, Alessandra;
    • Gentile, Massimo;
    • Pregno, Patrizia;
    • Gay, Francesca;
    • Botto, Barbara;
    • Frairia, Chiara;
    • Evangelista, Andrea;
    • Morabito, Fortunato;
    • Boccadoro, Mario;
    • Vitolo, Umberto;
    • Palumbo, Antonio
    Publication type:
    Article
    27

    Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma.

    Published in:
    Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00434-x
    By:
    • Bandini, Cecilia;
    • Mereu, Elisabetta;
    • Paradzik, Tina;
    • Labrador, Maria;
    • Maccagno, Monica;
    • Cumerlato, Michela;
    • Oreglia, Federico;
    • Prever, Lorenzo;
    • Manicardi, Veronica;
    • Taiana, Elisa;
    • Ronchetti, Domenica;
    • D'Agostino, Mattia;
    • Gay, Francesca;
    • Larocca, Alessandra;
    • Besse, Lenka;
    • Merlo, Giorgio Roberto;
    • Hirsch, Emilio;
    • Ciarrocchi, Alessia;
    • Inghirami, Giorgio;
    • Neri, Antonino
    Publication type:
    Article
    28
    29
    30
    31

    Patient‐reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 3, p. 639, doi. 10.1111/bjh.17887
    By:
    • Larocca, Alessandra;
    • Leleu, Xavier;
    • Touzeau, Cyrille;
    • Bladé, Joan;
    • Paner, Agne;
    • Mateos, María‐Victoria;
    • Cavo, Michele;
    • Maisel, Christopher;
    • Alegre, Adrían;
    • Oriol, Albert;
    • Raptis, Anastasios;
    • Rodriguez‐Otero, Paula;
    • Mazumder, Amitabha;
    • Laubach, Jacob;
    • Nadeem, Omar;
    • Sandberg, Anna;
    • Orre, Marie;
    • Torrång, Anna;
    • Bakker, Nicolaas A.;
    • Richardson, Paul G.
    Publication type:
    Article
    32
    33

    How is patient care for multiple myeloma advancing?

    Published in:
    Expert Review of Hematology, 2017, v. 10, n. 6, p. 551, doi. 10.1080/17474086.2017.1326814
    By:
    • Stavric, Sonja Genadieva;
    • Bonello, Francesca;
    • Bringhen, Sara;
    • Boccadoro, Mario;
    • Larocca, Alessandra
    Publication type:
    Article
    34
    35
    36

    Lenalidomide and its role in the management of multiple myeloma.

    Published in:
    Expert Review of Anticancer Therapy, 2008, v. 8, n. 6, p. 865, doi. 10.1586/14737140.8.6.865
    By:
    • Falco, Patrizia;
    • Cavallo, Federica;
    • Larocca, Alessandra;
    • Liberati, Anna Marina;
    • Musto, Pellegrino;
    • Boccadoro, Mario;
    • Palumbo, Antonio
    Publication type:
    Article
    37

    Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. 165, doi. 10.1016/j.clml.2023.10.009
    By:
    • Oriol, Albert;
    • Dimopoulos, Meletios;
    • Schjesvold, Fredrik;
    • Beksac, Meral;
    • Facon, Thierry;
    • Dhanasiri, Sujith;
    • Guo, Shien;
    • Mu, Yutian;
    • Hong, Kevin;
    • Gentili, Christian;
    • Galli, Monica;
    • Yagci, Munci;
    • Larocca, Alessandra;
    • Richardson, Paul;
    • Weisel, Katja
    Publication type:
    Article
    38

    P-065: CyTOF and single cell RNA sequencing reveal altered T cell phenotypes in Multiple Myeloma patients: implications for immunotherapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S74, doi. 10.1016/S2152-2650(21)02199-6
    By:
    • D'Agostino, Mattia;
    • Fincker, Maeva;
    • Panaroni, Cristina;
    • Yeri, Ashish;
    • Mao, Pingping;
    • Moulaison, Amanda;
    • Tassone, Ryan;
    • Estrada, Pedro Falcon;
    • Chen, Maggie;
    • Hu, Tiffany;
    • Genuardi, Elisa;
    • Larocca, Alessandra;
    • Boccadoro, Mario;
    • Iniguez, Amanda;
    • Finney, Olivia;
    • Bitter, Hans;
    • Raje, Noopur
    Publication type:
    Article
    39

    MM-186: HORIZON (OP-106): Melflufen Plus Dexamethasone in 55 Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD): Subgroup Analysis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S427, doi. 10.1016/S2152-2650(21)01953-4
    By:
    • Richardson, Paul G;
    • Mateos, María-Victoria;
    • Oriol, Albert;
    • Larocca, Alessandra;
    • Cavo, Michele;
    • Rodríguez-Otero, Paula;
    • Leleu, Xavier;
    • Norkin, Maxim;
    • Nadeem, Omar;
    • Hiemenz, John W;
    • Hassoun, Hani;
    • Touzeau, Cyrille;
    • Alegre, Adrián;
    • Paner, Agner;
    • Maisel, Christopher;
    • Mazumder, Amitabha;
    • Raptis, Anastasios;
    • Puig, Noemi;
    • Zamagni, Elena;
    • Thuresson, Marcus
    Publication type:
    Article
    40

    MM-171: Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Exposed or Refractory to Prior Alkylators: A Pooled Analysis of the O-12-M1 and HORIZON Studies.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S426, doi. 10.1016/S2152-2650(21)01952-2
    By:
    • Rodríguez-Otero, Paula;
    • Mateos, María-Victoria;
    • Oriol, Albert;
    • Larocca, Alessandra;
    • Blade, Joan;
    • Cavo, Michele;
    • Leleu, Xavier;
    • Nadeem, Omar;
    • Hiemenz, John W;
    • Hassoun, Hani;
    • Touzeau, Cyrille;
    • Alegre, Adrián;
    • Paner, Agne;
    • Maisel, Christopher;
    • Mazumder, Amitabha;
    • Raptis, Anastasios;
    • Thuresson, Marcus;
    • Harmenberg, Johan;
    • Harlin, Olof;
    • Richardson, Paul G
    Publication type:
    Article
    41

    Poster: MM-171: Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Exposed or Refractory to Prior Alkylators: A Pooled Analysis of the O-12-M1 and HORIZON Studies.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S251, doi. 10.1016/S2152-2650(21)01575-5
    By:
    • Rodríguez-Otero, Paula;
    • Mateos, María-Victoria;
    • Oriol, Albert;
    • Larocca, Alessandra;
    • Bladé, Joan;
    • Cavo, Michele;
    • Leleu, Xavier;
    • Nadeem, Omar;
    • Hiemenz, John W;
    • Hassoun, Hani;
    • Touzeau, Cyrille;
    • Alegre, Adrián;
    • Paner, Agne;
    • Maisel, Christopher;
    • Mazumder, Amitabha;
    • Raptis, Anastasios;
    • Thuresson, Marcus;
    • Harmenberg, Johan;
    • Harlin, Olof;
    • Richardson, Paul G
    Publication type:
    Article
    42

    Poster: MM-186: HORIZON (OP-106): Melflufen Plus Dexamethasone in 55 Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD): Subgroup Analysis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S250, doi. 10.1016/S2152-2650(21)01573-1
    By:
    • Richardson, Paul G.;
    • Mateos, María-Victoria;
    • Oriol, Albert;
    • Larocca, Alessandra;
    • Cavo, Michele;
    • Rodríguez-Otero, Paula;
    • Leleu, Xavier;
    • Norkin, Maxim;
    • Nadeem, Omar;
    • Hiemenz, John W;
    • Hassoun, Hani;
    • Touzeau, Cyrille;
    • Alegre, Adrián;
    • Paner, Agner;
    • Maisel, Christopher;
    • Mazumder, Amitabha;
    • Raptis, Anastasios;
    • Puig, Noemí;
    • Zamagni, Elena;
    • Thuresson, Marcus
    Publication type:
    Article
    43

    Activity of Melflufen in RR MM Patients with Extramedullary Disease in the Phase 2 HORIZON Study (OP-106): Promising Results in a High-Risk Population.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e352, doi. 10.1016/j.clml.2019.09.582
    By:
    • Richardson, Paul G.;
    • Mateos, Maria-Victoria;
    • Rodríguez-Otero, Paula;
    • Norkin, Maxim;
    • Larocca, Alessandra;
    • Hassoun, Hani;
    • Alegre, Adrian;
    • Paner, Agne;
    • Leleu, Xavier;
    • Maisel, Christopher;
    • Mazumder, Amitabha;
    • Harmenberg, Johan;
    • Byrne, Catriona;
    • Zubair, Hanan;
    • Thuresson, Sara;
    • Blade, Joan
    Publication type:
    Article
    44

    Maintenance Therapy vs Re-treatment at Biochemical Relapse vs Observation in Relapsed/Refractory Multiple Myeloma Patients: Results of a Phase II, Randomized Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e271, doi. 10.1016/j.clml.2019.09.447
    By:
    • Mina, Roberto;
    • Larocca, Alessandra;
    • Belotti, Angelo;
    • Conticello, Concetta;
    • Monaco, Federico;
    • Offidani, Massimo;
    • Ronconi, Sonia;
    • Marchetti, Monia;
    • Ria, Roberto;
    • Mosca-Siez, Maria Letizia;
    • Pescosta, Norbert;
    • Grasso, Mariella;
    • Capra, Andrea;
    • Zambello, Renato;
    • Poggiu, Marco;
    • Giuliani, Nicola;
    • Ballanti, Stelvio;
    • Cellini, Claudia;
    • Liberati, Anna Marina;
    • Siniscalchi, Agostina
    Publication type:
    Article
    45
    46

    Clinical and Biological Early Relapse Predictors in Multiple Myeloma: An Analysis from the MMRF CoMMpass Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e13, doi. 10.1016/j.clml.2019.09.019
    By:
    • D'Agostino, Mattia;
    • Zaccaria, Gian Maria;
    • Ziccheddu, Bachisio;
    • Genuardi, Elisa;
    • Maura, Francesco;
    • Oliva, Stefania;
    • Auclair, Daniel;
    • Yesil, Jennifer;
    • Capra, Andrea;
    • Colucci, Paola;
    • Poggiu, Marco;
    • Keats, Jonathan;
    • Larocca, Alessandra;
    • Gambella, Manuela;
    • Bolli, Niccolo;
    • Boccadoro, Mario;
    • Gay, Francesca
    Publication type:
    Article
    47

    HORIZON (OP-106) Study of Melflufen in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Refractory to Daratumumab and/or Pomalidomide: Updated Efficacy and Safety.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S329, doi. 10.1016/j.clml.2019.07.318
    By:
    • Richardson, Paul G.;
    • Oriol, Albert;
    • Larocca, Alessandra;
    • Otero, Paula Rodriguez;
    • Norkin, Maxim;
    • Bladé, Joan;
    • Cavo, Michele;
    • Hassoun, Hani;
    • Leleu, Xavier;
    • Alegre, Adrián;
    • Maisel, Christopher;
    • Paner, Agne;
    • Mazumder, Amitabha;
    • Zonder, Jeffrey A.;
    • Puig, Noemí;
    • Harran, John;
    • Harmenberg, Johan;
    • Thuresson, Sara;
    • Zubair, Hanan;
    • Mateos, Maria-Victoria
    Publication type:
    Article
    48

    Heavy+Light Chain and Free Light Chain Assays at Baseline and During Follow-up in EMN02/HO95 Multiple Myeloma Clinical Trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e47, doi. 10.1016/j.clml.2017.03.084
    By:
    • Omedè, Paola;
    • Redoglia, Valter;
    • Astolfi, Monica;
    • Larocca, Alessandra;
    • Spada, Stefano;
    • Bourlot, Luigi;
    • Cavo, Michele;
    • Petrucci, Maria Teresa;
    • Di Raimondo, Francesco;
    • Patriarca, Francesca;
    • Rambaldi, Alessandro;
    • Rossi, Giuseppe;
    • Ballanti, Stelvio;
    • Gamberi, Barbara;
    • Vincelli, Iolanda Donatella;
    • Grasso, Mariella;
    • Liberati, Anna Marina;
    • Corradini, Paolo;
    • Sonneveld, Pieter;
    • Boccadoro, Mario
    Publication type:
    Article
    49

    Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients: A Multicenter, Open Label Phase 1/2 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e59, doi. 10.1016/j.clml.2017.03.108
    By:
    • Bringhen, Sara;
    • Oliva, Stefania;
    • Liberati, Anna Marina;
    • Belotti, Angelo;
    • Larocca, Alessandra;
    • Bonello, Francesca;
    • Gaidano, Gianluca;
    • Bertazzoni, Paola;
    • Esma, Fabrizio;
    • Stocchi, Raffaella;
    • Malfitano, Alessandra;
    • Ribolla, Rossella;
    • Di Sano, Chiara;
    • Aschero, Simona;
    • Patriarca, Francesca;
    • De Paoli, Lorenzo;
    • Cafro, Anna Maria;
    • Sonneveld, Pieter;
    • Palumbo, Antonio;
    • Boccadoro, Mario
    Publication type:
    Article
    50

    Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial.

    Published in:
    Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. 1, doi. 10.1186/s13045-018-0691-4
    By:
    • Saltarella, Ilaria;
    • Morabito, Fortunato;
    • Giuliani, Nicola;
    • Terragna, Carolina;
    • Omedè, Paola;
    • Palumbo, Antonio;
    • Bringhen, Sara;
    • De Paoli, Lorenzo;
    • Martino, Enrica;
    • Larocca, Alessandra;
    • Offidani, Massimo;
    • Patriarca, Francesca;
    • Nozzoli, Chiara;
    • Guglielmelli, Tommasina;
    • Benevolo, Giulia;
    • Callea, Vincenzo;
    • Baldini, Luca;
    • Grasso, Mariella;
    • Leonardi, Giovanna;
    • Rizzo, Manuela
    Publication type:
    Article